The BYOD approach in clinical trials follows a patient-centered approach and offers distinct advantages:   Participant Familiarity: Utilizing their own devices, participants interact with a familiar interface, minimizing learning curves and enhancing their comfort level. Rapid Deployment: BYOD expedites the setup process, as participants are using existing devices, facilitating quicker trial initiation and progress. Reduced Equipment Costs: BYOD negates the need for purchasing and maintaining dedicated trial devices, offering a more cost-efficient solution. Adaptability to Different Trial Phases: The Clinical ink platform can be tailored to suit various trial designs, phases, and therapeutic areas, providing flexibility without compromising integrity or compliance. Remote Accessibility: BYOD supports Decentralized Clinical Trials (DCTs) and remote participation, making trials more accessible and diverse in their reach.